These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


211 related items for PubMed ID: 29428146

  • 1. Management of Perioperative Anticoagulation for Device Implantation.
    Stewart MH, Morin DP.
    Card Electrophysiol Clin; 2018 Mar; 10(1):99-109. PubMed ID: 29428146
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Pacemaker or defibrillator surgery without interruption of anticoagulation.
    Birnie DH, Healey JS, Wells GA, Verma A, Tang AS, Krahn AD, Simpson CS, Ayala-Paredes F, Coutu B, Leiria TL, Essebag V, BRUISE CONTROL Investigators.
    N Engl J Med; 2013 May 30; 368(22):2084-93. PubMed ID: 23659733
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Managing anticoagulation in patients receiving implantable cardiac devices.
    Chousou PA, Pugh PJ.
    Future Cardiol; 2018 Mar 30; 14(2):151-164. PubMed ID: 29226707
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Continuation of warfarin during pacemaker or implantable cardioverter-defibrillator implantation: a randomized clinical trial.
    Cheng A, Nazarian S, Brinker JA, Tompkins C, Spragg DD, Leng CT, Halperin H, Tandri H, Sinha SK, Marine JE, Calkins H, Tomaselli GF, Berger RD, Henrikson CA.
    Heart Rhythm; 2011 Apr 30; 8(4):536-40. PubMed ID: 21147261
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Cost effectiveness of continued-warfarin versus heparin-bridging therapy during pacemaker and defibrillator surgery.
    Coyle D, Coyle K, Essebag V, Birnie DH, Ahmad K, Toal S, Sapp J, Healey JS, Verma A, Wells G, Krahn AD.
    J Am Coll Cardiol; 2015 Mar 10; 65(9):957-9. PubMed ID: 25744016
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Implanting cardiac rhythm devices during uninterrupted warfarin therapy: a prospective, single center experience.
    Crosato M, Calzolari V, Franceschini Grisolia E, Daniotti A, Baldessin F, Mantovan R, Olivari Z.
    J Cardiovasc Med (Hagerstown); 2015 Jul 10; 16(7):503-6. PubMed ID: 25022924
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Perioperative management of antithrombotic treatment during implantation or revision of cardiac implantable electronic devices: the European Snapshot Survey on Procedural Routines for Electronic Device Implantation (ESS-PREDI).
    Deharo JC, Sciaraffia E, Leclercq C, Amara W, Doering M, Bongiorni MG, Chen J, Dagres N, Estner H, Larsen TB, Johansen JB, Potpara TS, Proclemer A, Pison L, Brunet C, Blomström-Lundqvist C, Coordinated by the Scientific Initiatives Committee of the European Heart Rhythm Association.
    Europace; 2016 May 10; 18(5):778-84. PubMed ID: 27226497
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Dual antiplatelet therapy and heparin "bridging" significantly increase the risk of bleeding complications after pacemaker or implantable cardioverter-defibrillator device implantation.
    Tompkins C, Cheng A, Dalal D, Brinker JA, Leng CT, Marine JE, Nazarian S, Spragg DD, Sinha S, Halperin H, Tomaselli GF, Berger RD, Calkins H, Henrikson CA.
    J Am Coll Cardiol; 2010 May 25; 55(21):2376-82. PubMed ID: 20488310
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.